BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Diagnosis
27 results:

  • 1. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
    Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
    Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Characterizing the distribution of alterations in mesothelioma and their correlation to morphology.
    Chen-Yost HI; Tjota MY; Gao G; Mitchell O; Kindler H; Segal J; Husain AN; Mueller J; Schulte JJ
    Am J Clin Pathol; 2023 Sep; 160(3):238-246. PubMed ID: 37141416
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mesotheliomas and Benign Mesothelial Tumors: Update on Pathologic and Imaging Findings.
    Bonde A; Singh R; Prasad SR; Kamireddy D; Aggarwal A; Ramani N; Saboo S; Shanbhogue K; Dasyam AK; Katabathina VS
    Radiographics; 2023 Mar; 43(3):e220128. PubMed ID: 36757881
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Peritoneal Mesothelioma-An Update.
    Malpica A
    Adv Anat Pathol; 2023 Jul; 30(4):262-274. PubMed ID: 36729766
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Rocky Road from Preclinical Findings to Successful Targeted Therapy in Pleural Mesothelioma.
    Paajanen J; Bueno R; De Rienzo A
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362209
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Neurofibromatosis from Head to Toe: What the Radiologist Needs to Know.
    Wang MX; Dillman JR; Guccione J; Habiba A; Maher M; Kamel S; Panse PM; Jensen CT; Elsayes KM
    Radiographics; 2022; 42(4):1123-1144. PubMed ID: 35749292
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Update of pathological diagnosis of pleural mesothelioma using genomic-based morphological techniques, for both histological and cytological investigations.
    Nabeshima K; Hamasaki M; Kinoshita Y; Matsumoto S; Sa-Ngiamwibool P
    Pathol Int; 2022 Aug; 72(8):389-401. PubMed ID: 35596704
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical and molecular validation of BAP1, MTAP, P53, and merlin immunohistochemistry in diagnosis of pleural mesothelioma.
    Chapel DB; Hornick JL; Barlow J; Bueno R; Sholl LM
    Mod Pathol; 2022 Oct; 35(10):1383-1397. PubMed ID: 35459788
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Identification and Analysis of MicroRNAs Combined Biomarkers for Hepatocellular Carcinoma diagnosis.
    Shi Y; Men J; Sun H; Tan J
    Med Chem; 2022; 18(10):1073-1085. PubMed ID: 35379158
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic Mimics.
    Bertero L; Righi L; Collemi G; Koelsche C; Hou Y; Stichel D; Schrimpf D; Flucke U; Petersen I; Vokuhl C; Fröhling S; Bironzo P; Scagliotti GV; Cassoni P; Papotti M; von Deimling A
    J Mol Diagn; 2021 Jul; 23(7):834-846. PubMed ID: 33887463
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Fluorescence in situ hybridization detection of chromosome 22 monosomy in pleural effusion cytology for the diagnosis of mesothelioma.
    Kinoshita Y; Hamasaki M; Matsumoto S; Yoshimura M; Sato A; Tsujimura T; Kamei T; Kawahara K; Iwasaki A; Nabeshima K
    Cancer Cytopathol; 2021 Jul; 129(7):526-536. PubMed ID: 33493384
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genomic characterization of malignant pleural mesothelioma and associated clinical outcomes.
    Markowitz P; Patel M; Groisberg R; Aisner J; Jabbour SK; De S; Ganesan S; Malhotra J
    Cancer Treat Res Commun; 2020; 25():100232. PubMed ID: 33166854
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Standardized uptake value (SUV
    Haghighat Jahromi A; Chang G; Kurzrock R; Hoh CK
    Cancer Biol Ther; 2020 Nov; 21(11):1067-1071. PubMed ID: 33131408
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. An intrathoracic schwannoma case in
    Gültekin A; Aydoğmuş Ü; Arifoğlu H; Bir F; Yaylalı O
    Hell J Nucl Med; 2020; 23(2):206-208. PubMed ID: 32716413
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hemizygous loss of nf2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma.
    Kinoshita Y; Hamasaki M; Yoshimura M; Matsumoto S; Iwasaki A; Nabeshima K
    Mod Pathol; 2020 Feb; 33(2):235-244. PubMed ID: 31231129
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Multiple spindle cell hemangiomas in both lungs: a rare case report and review of the literature.
    Duqing X; Zhaohong W; Gefei W
    J Cardiothorac Surg; 2019 May; 14(1):86. PubMed ID: 31046794
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Establishment and characterization of CRISPR/Cas9-mediated nf2
    Wahiduzzaman M; Karnan S; Ota A; Hanamura I; Murakami H; Inoko A; Rahman ML; Hyodo T; Konishi H; Tsuzuki S; Hosokawa Y
    Cancer Sci; 2019 Jan; 110(1):180-193. PubMed ID: 30417500
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Malignant mesothelioma in situ.
    Churg A; Hwang H; Tan L; Qing G; Taher A; Tong A; Bilawich AM; Dacic S
    Histopathology; 2018 May; 72(6):1033-1038. PubMed ID: 29350783
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genomic characterisation of two cancers of unknown primary cases supports a kidney cancer origin.
    Wei EY; Chen YB; Hsieh JJ
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26494726
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pleural neoplastic pathology.
    Karpathiou G; Stefanou D; Froudarakis ME
    Respir Med; 2015 Aug; 109(8):931-43. PubMed ID: 26048082
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.